Repurposed Medications & Targeted Supplement Care
Medically Supervised Antiparasitics, Metabolic Modulators & High-Potency Nutraceuticals
DR. WILLIAM MAKIS' CLINICAL APPROACH
Targeting cancer cell metabolism, microtubule dynamics, and stem cell pathways using well-studied repurposed compounds.
Repurposed medications such as Ivermectin, Fenbendazole, Mebendazole, and Hydroxychloroquine have demonstrated significant anti-tumor and immunomodulatory mechanisms in preclinical and clinical literature.
By combining structured medication cycling with targeted organ support (TUDCA, NAC, Milk Thistle) and synergistic nutraceuticals (Curcumin, Quercetin, Berberine), Dr. William Makis constructs personalized treatment roadmaps designed for optimal biological efficacy.
Repurposed Drug Synergy Matrix
Combining antiparasitic compounds (Ivermectin, Fenbendazole, Mebendazole) with metabolic regulators and cellular detoxification agents for multi-pathway cancer targeting.
ANTIPARASITIC & ANTI-MITOTIC
Benzimidazoles & Avermectins
Fenbendazole, Mebendazole, and Ivermectin target tumor tubulin assembly, disrupt glucose utilization (GLUT-1), and inhibit Wnt/β-catenin signaling in resistant cancer cell populations.
METABOLIC MODULATION
AMPK & Glycolysis Regulation
Utilizing Hydroxychloroquine, Berberine, and Metformin to disrupt tumor autophagic rescue mechanisms, suppress lactate production, and starve metabolic cancer pathways.
DETOX & ORGAN PROTECTION
Spike Detox & Hepatic Shield
Targeted proteolytic enzymes (Nattokinase, Bromelain) and hepatoprotective compounds (TUDCA, NAC, Glutathione) prevent Herxheimer reactions and protect liver function during active protocol cycling.
CLINICAL INSIGHTS & PRESENTATIONS
Watch Dr. William Makis, MD
Watch recent video shorts and clinical discussions with Dr. William Makis on repurposed medications, targeted cancer protocols, and spike protein detoxification.
PRACTITIONER-GRADE FORMULATIONS
Targeted Protocol Supplements
High-purity, bioavailable nutraceuticals specifically selected by Dr. William Makis to enhance protocol synergy and organ protection.
PHYSICIAN & RESEARCH LEAD
Meet Dr. William Makis, MD
MD, FRCPC | Repurposed Medications & Integrative Oncology
Dr. William Makis, MD, FRCPC is a Canadian physician and medical researcher specializing in nuclear medicine, radiology, and targeted cancer therapeutics. With over 100 peer-reviewed medical publications, Dr. Makis is an internationally recognized pioneer in repurposed medication protocols for oncology and spike protein detoxification.
Through comprehensive clinical consultations, Dr. Makis evaluates individual medical histories, pathology reports, and biomarker data to construct evidence-informed repurposed drug and supplement roadmaps.
Read Dr. Makis' Full Bio & ResearchRESEARCH & MEDICAL INSIGHTS
Latest Blog Posts & Articles
Repurposed Medications in Integrative Oncology
Dr. William Makis explains repurposed drug protocols.
NEW ARTICLE: Ivermectin and Fenbendazole Testimonial – Stage 4 GastroEso...
Not every Ivermectin Cancer success story is a happy success story. The body can improve but the mind may not always follow.Pat...
COMMON QUESTIONS
Frequently Asked Questions
Clear answers regarding oncologist collaboration, telemedicine availability, record requirements, timeline, and protocol personalization.
START YOUR PERSONALIZED PROTOCOL
Ready to Explore Repurposed Drug Protocols with Dr. William Makis?
Schedule an in-person appointment in San Francisco, CA or request a secure telemedicine record review to receive your individualized treatment roadmap.